NEW YORK (GenomeWeb) – Epigenomics said today that it will receive a two-year, €2.8 million ($3.1 million) EU grant to fund clinical research to validate the company's lung cancer biomarkers.

The grant will be administered through the Industrial Leadership pillar of the EU's Horizon 2020 Research and Innovation Program for Small and Medium Enterprise Businesses.

The ultimate goal of Epigenomics' project is to develop a CE-marked product to detect lung cancer in blood plasma, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.